Judge dismisses lawsuit alleging Bayer tried to monopolize dicamba-resistant seed market

DicambaSoybeans e
A farmer shows the damage caused by dicamba drift, resulting in "cupped" leaves on affected crops

A federal court has granted Monsanto’s move to dismiss a complaint filed by a Missouri farmer alleging a conspiracy to monopolize a more-expensive seed.

U.S. District Judge Stephen Limbaugh Jr….stated the plaintiffs did not “adequately” show they were direct seed purchasers, according to a March 13 order. He cited Kloth v. Microsoft Corp. in which the Fourth Circuit Court ruled that even though consumers entered into a license agreement to purchase software, it does not make the consumer a “direct purchaser.”

Plaintiffs Sam Branum, a Missouri farmer, and Wapsie Farms Partnership alleged Monsanto had “artificially increased demand” of its herbicide-resistant Xtend seeds to gain “monopolistic profits,” the ruling states….

According to the court filing, Monsanto developed Xtend seeds, which contain a genetic trait that allows them to tolerate herbicide application such as Roundup and dicamba. Since the dicamba herbicide tends to “drift” to other crops and cause damage, Monsanto allegedly joined forces with the makers of dicamba, BASF Corp., to develop a “new dicamba” called XtendiMax that would be less prone to drift to other crops and cause damage like the original dicamba.

Read full, original article: Judge grants Mosanto’s motion to dismiss farmers’ suit over Xtend seeds

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
artificial intelligence brain think illustration md
Viewpoint — Digital gods and human extinction: Will we be the first species ever to design our own descendants?
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT Image May 12, 2026, 01_21_30 PM
How big health brands are funding online medical misinformation 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.